DNASE1L3 and systemic lupus erythematosus: In experimental models, DNase I reduces inflammation in rheumatoid arthritis and colitis, although its efficacy is reduced in systemic lupus erythematosus (SLE) due to the presence of NET-stabilizing proteins.